July 27, 2023 12:29 PM EDTUpdated 12:51 PM

As pressure mounts to take action on drug shortages, lawmakers seek to boost production in the US

Lia DeGroot

A bipartisan group of senators introduced legislation on Thursday that aims to bolster domestic generic manufacturing in an effort to shore up stockpiles of key …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

As pressure mounts to take action on drug shortages, lawmakers seek to boost production in the US

Lia DeGroot

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

As pres­sure mounts to take ac­tion on drug short­ages, law­mak­ers seek to boost pro­duc­tion in the US

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

As pressure mounts to take action on drug shortages, lawmakers seek to boost production in the US